| abstract |
FIELD: medicine. SUBSTANCE: described are new compounds which are 2-amino-1,2,3,4- tetrahydronaphthalene derivatives of formula I: intended for medical treatment of arterial hypertension, myocardial deficiency, kidney deficiency, peripheral arteriopathies or cerebrovascular deficiencies. Said compounds have activities and prolonged activity and are capable of being absorbed when administered orally. EFFECT: improved properties of the title compounds. 7 cl, 100 ex, 4 tbl |